Suchergebnisse - "White, Nicholas J"

PubPharm (125)

1

Clinical antiviral efficacy of favipiravir in early COVID-19 (PLATCOV) : an open-label, randomised, controlled, adaptive platform trial

enthalten in: BMC infectious diseases | 2024

von Luvira, V. | Schilling, W. | Jittamala, P. | +33

2

Antiviral efficacy of molnupiravir versus ritonavir-boosted nirmatrelvir in patients with early symptomatic COVID-19 (PLATCOV) : an open-label, phase 2, randomised, controlled, adaptive trial

enthalten in: The Lancet. Infectious diseases | 2024

von Schilling, W. | Jittamala, P. | Watson, J. | +89

ErratumIn: Lancet Infect Dis. 2023 Dec;23(12):e511. - PMID 37839427

3

Clinical Antiviral Efficacy of Remdesivir in Coronavirus Disease 2019 : An Open-Label, Randomized Controlled Adaptive Platform Trial (PLATCOV)

enthalten in: The Journal of infectious diseases | 2023

von Jittamala, P. | Schilling, W. | Watson, J. | +81

4

Weekly primaquine for radical cure of patients with Plasmodium vivax malaria and glucose-6-phosphate dehydrogenase deficiency

enthalten in: PLoS neglected tropical diseases | 2023

von Taylor, W. | Meagher, N. | Ley, B. | +26

5

The heterogeneity of symptom reporting across study sites : a secondary analysis of a randomised placebo-controlled multicentre antimalarial trial

enthalten in: BMC medical research methodology | 2023

von Thriemer, K. | Commons, R. | Rajasekhar, M. | +24

6

Safety and efficacy of artesunate treatment in severely injured patients with traumatic hemorrhage. The TOP-ART randomized clinical trial

enthalten in: Intensive care medicine | 2023

von Shepherd, J. | Ross, J. | Anton, L. | +6

CommentIn: Intensive Care Med. 2023 Aug;49(8):977-978. - PMID 37466669

7

Pharmacometrics of high-dose ivermectin in early COVID-19 from an open label, randomized, controlled adaptive platform trial (PLATCOV)

enthalten in: eLife | 2023

von Schilling, W. | Jittamala, P. | Watson, J. | +36

8

Antimalarial chemoprophylaxis for forest goers in southeast Asia : an open-label, individually randomised controlled trial

enthalten in: The Lancet. Infectious diseases | 2023

von Tripura, R. | von Seidlein, L. | Sovannaroth, S. | +23

CommentIn: Lancet Infect Dis. 2023 Jan;23(1):8-10. - PMID 36174594

9

Modelling the optimal dosing schedule for artemether-lumefantrine chemoprophylaxis against malaria

enthalten in: BMC research notes | 2022

von Tarning, J. | von Seidlein, L. | Dondorp, A. | +2

10

Triple therapy with artemether-lumefantrine plus amodiaquine versus artemether-lumefantrine alone for artemisinin-resistant, uncomplicated falciparum malaria : an open-label, randomised, multicentre trial

enthalten in: The Lancet. Infectious diseases | 2022

von Peto, T. | Tripura, R. | Callery, J. | +30

CommentIn: Lancet Infect Dis. 2022 Jun;22(6):751-753. - PMID 35276063

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[13]